Japan Lipid Market Size & Outlook, 2022-2030
Japan lipid market, 2018-2030 (US$M)
Related Markets
Japan lipid market highlights
- The Japan lipid market generated a revenue of USD 495.5 million in 2022 and is expected to reach USD 835.6 million by 2030.
- The Japan market is expected to grow at a CAGR of 6.8% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 495.5 million |
| Market revenue in 2030 | USD 835.6 million |
| Growth rate | 6.8% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Japan accounted for 5.3% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Japan lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The Japanese population has been keen on the consumption of omega-3 in their regular diet for a long time, primarily from fish and fish oils. The consumption of omega-3-based food has been further boosted owing to the easy availability of omega-3 dietary supplements and functional food.
It is speculated that the reason behind lower COVID-19 casualties in Japan than in other countries was the high level of consumption of omega-3 in the typical diet of the population. Furthermore, high consumption of omega-3 keeps cholesterol under control, which reduces the risk of a heart attack.
Japan has the presence of numerous omega-3 producers, including Novasep, KD Pharma Group, Bizen Chemical Co., and AlaskOmega. Growing awareness of the benefits of omega 3 is expected to drive its demand, thereby, positively influencing the market for lipids in Japan over the forecasted years.
Reasons to subscribe to Japan lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan lipid market , including forecasts for subscribers. This country databook contains high-level insights into Japan lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan lipid market size, by phase, 2018-2030 (US$M)
Japan Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
